Fortrea Holdings Inc. (FTRE)

Market Cap	1.68B
Revenue (ttm)	2.98B
Net Income (ttm)	-300.00M
Shares Out	89.70M
EPS (ttm)	-3.36
PE Ratio	n/a
Forward PE	15.65
Dividend	n/a
Ex-Dividend Date	n/a

Volume	674,957
Open	17.88
Previous Close	17.69
Day's Range	17.64 - 18.81
52-Week Range	16.53 - 41.02
Beta	n/a
Analysts	Hold
Price Target	23.30 (+24.6%)
Earnings Date	Mar 10, 2025

About FTRE

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1996
• Employees: 18,000
• Stock Exchange: NASDAQ
• Ticker Symbol: FTRE
• Website: https://www.fortrea.com

Analyst Forecast

According to 11 analysts, the average rating for FTRE stock is "Hold." The 12-month stock price forecast is $23.3, which is an increase of 24.60% from the latest price.

Price Target

$23.3

(24.60% upside)

Analyst Consensus: Hold